

Drug Class: Aromatase Inhibitor (AI)
Composition: Letrozole
Dosage: 2.5 mg/tablet
Form: Oral Tablets
Unit: 100 Tablets
Brand: Dragon Pharma
For Oral Administration
For elite bodybuilders and athletes in the USA who employ massively aromatizing anabolic cycles, standard estrogen management is often insufficient. Dragon Pharma Femara, powered by the exceptionally potent active substance Letrozole, stands as the most powerful Aromatase Inhibitor (AI) available. It is the definitive choice when aggressive estrogen suppression is non-negotiable. While its power demands respect, Femara is an invaluable tool for those running gram-plus testosterone cycles, heavy androgen stacks, or for individuals who are genetically prone to severe estrogenic side effects. It represents the pinnacle of estrogen control in the performance enhancement world.
Femara is a non-steroidal, competitive aromatase inhibitor that works by binding to the heme group of the aromatase enzyme, effectively shutting down the conversion of androgens into estrogen throughout the body. Its effects are profound and distinct from other AIs:
According to research published by the National Library of Medicine, Letrozole is a highly selective, non-steroidal, third-generation aromatase inhibitor with superior efficacy in reducing estrogen synthesis compared to earlier agents.
Dosing Femara requires extreme caution and precision. Its potency means that the margin for error is small, and the risk of crashing estrogen is high. The 2.5mg tablet is designed to be split for accurate, low-dose administration.
Critical Warning: Never start with a full 2.5mg tablet. Always begin with the lowest possible dose and increase only if necessary. Crashing your estrogen with Femara leads to severe joint pain, zero libido, crippling fatigue, and destroyed lipid values. The Dragon Pharma 2.5mg tablet is scored, allowing for precise splitting into quarters (0.625mg) or eighths (0.3125mg) for safe dosing.
Femara is not a first-line AI for beginner or moderate cycles. Its application is specific to advanced, high-estrogen scenarios.
When is Femara the Right Choice?
Sample Cycle Stacks Requiring Femara:
Using Femara responsibly requires a comprehensive approach to cycle support and health management.
The side effects of Femara are primarily a direct result of its extreme potency and the subsequent hormonal environment it creates.
By choosing Dragon Pharma, you are selecting a product from a reputable source, ensuring you receive a genuine and accurately dosed tablet, which is absolutely critical when dealing with a compound as powerful as Letrozole.
Name: Femara
Drug Class: Aromatase Inhibitor (AI), Non-Steroidal
Other common names and terms: Letrozole, 'Letro'
Active Life: Approximately 2-4 days
Detection Time: Approximately 2-3 weeks
Chemical Structure: 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile
Common Doses: 0.25mg, 0.5mg, 1.25mg, 2.5mg (taken orally every other day or twice weekly)
Blood pressure: Can lower elevated blood pressure caused by estrogenic water retention.
Acne: Can reduce estrogen-related acne but may increase androgenic acne.
Water retention: Extremely effective at eliminating subcutaneous water retention.
Aromatisation: Does not aromatize; it is the most potent inhibitor of the aromatase enzyme.
Liver toxicity: Not liver toxic.
Decrease HPTA function: Does not directly suppress the HPTA, but is used to manage the side effects of suppressive compounds.
Femara is in a league of its own in terms of raw potency. It is considered the strongest aromatase inhibitor available. Arimidex (Anastrozole) is a powerful non-steroidal AI, but Letrozole has been shown to suppress estrogen more completely. Aromasin (Exemestane) is a steroidal, suicidal AI that permanently deactivates the enzyme and has a different side-effect profile, particularly being milder on lipids. Arimidex and Aromasin are suitable for the vast majority of cycles. Femara is reserved for extreme situations: very high-dose cycles, individuals who are hyper-responders to estrogen, or as a last-resort treatment for stubborn gynecomastia.
If you experience severe joint pain, zero libido, and deep fatigue, you have likely crashed your estrogen. The protocol is as follows: 1) Stop taking Femara immediately. 2) Do not take any AI until symptoms fully resolve, which could take 1-3 weeks. 3) You may consider a one-time "reset" dose of a mild aromatizing compound like 25-50mg of Dianabol 20 or a small injection of testosterone to quickly reintroduce estrogen. 4) Once recovered, if you still need an AI, restart with a much lower dose (e.g., 0.25mg twice a week) or switch to a milder AI like Aromasin.
Yes, Femara is the most effective pharmaceutical AI for reducing existing gynecomastia due to its powerful estrogen-suppressing capabilities. It can shrink the glandular tissue, especially if the gyno is recent and not yet fibrotic. A common protocol is to use a dose of 1.25mg to 2.5mg every other day for 1-3 weeks, then reassess. It is often stacked with a SERM like Nolvadex (which blocks the estrogen receptor in the breast tissue directly) for a synergistic attack on gyno. However, this is a powerful hormonal intervention and should be approached with caution.
Femara's primary cardiovascular risk stems from its dramatic impact on blood lipids. It significantly lowers HDL (the "good" cholesterol) and can increase LDL (the "bad" cholesterol), creating a more atherogenic profile. This effect is more pronounced with Letrozole than with other AIs. Long-term, this can increase the risk of atherosclerosis and cardiovascular events. Therefore, using Femara necessitates proactive heart health measures: consistent cardio, a diet rich in omega-3 fatty acids and fiber, and regular blood work to monitor lipid panels. It should not be used casually or for extended periods.
Absolutely not. Dragon Pharma Femara is an advanced-grade compound intended for experienced users who have a deep understanding of their body's response to estrogen management. Its potency is so great that a new user would have an extremely high risk of completely crashing their estrogen, leading to a miserable experience and potential health risks. First-time users should always start with a milder AI like Aromasin or Arimidex to learn how their body responds to estrogen control. Femara should only be considered when these milder options have proven inadequate for managing estrogen on very heavy cycles or for addressing severe, pre-existing side effects.
Please log in to write Femara 2.5 mg review.
Drug Class: Aromatase Inhibitor (AI), Steroidal
Composition: Exemestane
Dosage: 25 mg/tablet
Form: Oral Tablets
Unit: 100 Tablets
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Oral Administration
Drug Class: Aromatase Inhibitor (AI)
Composition: Anastrozole
Dosage: 1 mg/tablet
Form: Oral Tablets
Unit: 100 Tablets
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Oral Administration
Drug Class: Selective Estrogen Receptor Modulator (SERM)
Composition: Clomiphene Citrate
Dosage: 50 mg/tablet
Form: Oral Tablets
Unit: 100 Tablets
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Oral Administration
Drug Class: Retinoid (Vitamin A derivative)
Composition: Isotretinoin
Dosage: 20 mg/tablet
Form: Oral Tablets
Unit: 100 Tablets
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Oral Administration
Drug Class: Selective Estrogen Receptor Modulator (SERM)
Composition: Tamoxifen Citrate
Dosage: 20 mg/tablet
Form: Oral Tablets
Unit: 100 Tablets
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Oral Administration